We’re hiring a Senior Product Lead for AIRCHECK at UHN and the Structural Genomics Consortium. Help build a scalable open-science platform for sharing FAIR, AI-ready chemical screening data with the global drug discovery community. Apply by August 12: jobs.smartrecruiters.com/UniversityHe...
The future of AI will depend not only on what the technology can do, but on how much people can trust it. UHN's Dr. @bhaibeka.bsky.social highlights that transparency and openness are critical to building systems in health care that are safe, ethical, and worthy of public confidence.
How do we ensure AI is safe, trustworthy and effective in cancer care and research? Meet Dr. @bhaibeka.bsky.social Executive AI Scientific Director @uhn.ca, Senior Scientist and Scientific Director of Cancer Digital Intelligence program at Princess Margaret Cancer Centre. youtu.be/yIOPi6EK3DM?...
We’re hiring a Senior Product Lead for AIRCHECK at UHN and the Structural Genomics Consortium. Help build a scalable open-science platform for sharing FAIR, AI-ready chemical screening data with the global drug discovery community. Apply by August 12: jobs.smartrecruiters.com/UniversityHe...
Learn more on how he's developing AI guardrails for safe health care: www.uhnresearch.ca/news/7-29-20...
Meet Dr. Benjamin Haibe-Kains @PMResearch | UHN Research
University Health Network (UHN) is a research hospital affiliated with the University of Toronto and a member of the Toronto Academic Health Science Network. The scope of research and complexity of ca...
uhnresearch.ca
How do we ensure AI is safe, trustworthy and effective in cancer care and research? Meet Dr. @bhaibeka.bsky.social Executive AI Scientific Director @uhn.ca, Senior Scientist and Scientific Director of Cancer Digital Intelligence program at Princess Margaret Cancer Centre. youtu.be/yIOPi6EK3DM?...
Meet Dr. Benjamin Haibe Kains: Transparent AI Research for Safe Health Care
YouTube video by UHN Research
youtu.be
Join us at the Target 2035 Symposium on September 23 for our AIRCHECK workshop and a conversation about data-driven drug discovery. @thesgc.bsky.social event.fourwaves.com/target2035sy...
#AACRFellows William Sellers discussed “Therapeutic Resistance as a Path to Combination Therapy” in a keynote lecture during the AACR Conference on Drug Discovery and Development. #AACRdrugdev26
Elizabeth Jaffee, Jayesh Desai, Sarah Goldberg, Anthony Joshua, Anirban Maitra, and Puja Sapra discussed "Accelerating Investigator-Initiated Clinical Trials with Team Science" during a special session at #AACRdrugdev26. @anirbanmaitra.bsky.social
AI in Oncology: Facts and Hopes— Sarah Skerratt, Jorge Reis-Filho, and Benjamin Haibe-Kains addressed this topic in a plenary session at the AACR Conference on Drug Discovery and Development. #AACRdrugdev26 @bhaibeka.bsky.social
Poster presenters shared their work with attendees Wednesday evening during the AACR Conference on Drug Discovery and Development. The meeting continues through Friday in Boston. #AACRdrugdev26
UHN’s president and CEO is challenging government, industry and academia to think bigger and act faster. Dr. Kevin Smith has a bold proposal to accelerate health innovation for Canadian patients, communities and the economy here at home. Learn more:
UHN’s Kevin Smith has a grand vision to supercharge Canada’s health science sector
The CEO of Toronto’s University Health Network has a bold proposal: Canadian world domination in clinical enterprises
begiant.ca
Congratulations to Dr. @bhaibeka.bsky.social on receiving the 2026 inaugural Francis Ouellette Community Award! 🎉 Recognized for his leadership in open science, community building & advancing inclusive, bias-aware AI in computational biology. @uhnresearch.ca @uhn.ca www.linkedin.com/posts/canadi...
It didn’t cost toy 300 billion USD, so far… (ignoring the costs of the actual war, of course).
Very happy to share our lab‘s latest work, published in Nature last week 👇
Papers in Nature present two independent #AI models that can assist with multiple stages of patient management, from diagnosis to treatment decisions. The systems demonstrate the potential for conversational AI tools to help with disease management. go.nature.com/4oyINh9 go.nature.com/4oAalCx 🧪
Our new study shows that a methylation-based blood test measuring tumour DNA can accurately monitor treatment response & detect signs of treatment failure a median of six months before clinical progression in metastatic breast cancer patients. www.nature.com/articles/s41... @uhn.ca @uhnresearch.ca
TFRI and @marathonofhope.bsky.social are proud to congratulate Dr. Morag Park on her appointment as President and Scientific Director of the Gairdner Foundation. Learn more about Dr. Park's contributions to the TFRI community and Canadian cancer research: www.tfri.ca/updates/news...
Congratulations to Dr. Daniel Schramek #LTRI on receiving the prestigious #DorvalPrize from the @cancersociety.bsky.social for expanding our understanding of cancer & opening doors to new treatments 👏👏 Read more: https://bit.ly/4vU67Is #SinaiHealth #CancerResearch #LTRI
🧫 What if doctors could test cancer drugs on a patient's tumour before choosing a treatment? 🧫 Read the full Q&A with Dr. Robert Grant to learn how organoid-based drug testing could help improve treatment options for pancreatic cancer patients: www.marathonofhopecancercentres.ca/impact/news-...
Exciting times ahead! 🇨🇦 Five takeways from #Canada's new #AI strategy www.bbc.com/news/article... #AIhealth #AI #HealthAI #MedTech
Five takeways from Canada's new AI strategy
Canada new roadmap for how it plans to adopt AI over the next decade includes "large-scale" data centres, free AI literacy programme and billions in funding.
bbc.com
Proud to host PM @mark-carney.bsky.social, Diana Fox Carney and @evansolomon.bsky.social at UHN. We are excited to partner in shaping the future of AI-enabled health care.
We built a joint experimental and computational platform for scalable multi-modal single-cell chemical screens — profiling RNA, protein (including phospho-signaling), and chromatin accessibility responses to thousands of small molecule perturbations in parallel. www.biorxiv.org/content/10.6...
This month, the 15th Annual Princess Margaret Cancer Centre Research Retreat took place to build collaborations among scientists and clinicians, and to accelerate discoveries that will address patient needs. Congratulations to all our 2026 research award winners! www.linkedin.com/feed/update/...
The Computational Biology and Medicine Program at Princess Margaret Cancer Centre in Toronto is hiring a Program and Data Management Coordinator. Come join us! Applications close 26 May. jobs.smartrecruiters.com/UniversityHe...
Program Coordinator
Company Description: UHN is Canada’s #1 hospital and the world’s #1 publicly funded hospital. With 10 sites and more than 44,000 TeamUHN members, UHN consists of Toronto General Hospital, Toronto West...
jobs.smartrecruiters.com
AI in Oncology: Facts and Hopes— Sarah Skerratt, Jorge Reis-Filho, and Benjamin Haibe-Kains will address this topic in a plenary session at the AACR D3 Conference on Drug Discovery and Development (July 21-24; Boston). Learn more: buff.ly/DIXf26I #AACRdrugdev26 @bhaibeka.bsky.social
If you missed our Special Session at the #AACR Annual Meeting, you can still catch the key insights in the latest edition of Discover 👇 Take a closer look at the science with Allan Balmain and Mike Stratton: features.cancergrandchallenges.org/impact/
Artificial intelligence in patient care requires a rigorous approach to build trust. Suchi Saria highlighted this need while discussing real-world health care applications at #AACR26. Read the full recap in AACR Annual Meeting News: buff.ly/MVZEgpH
On Monday at #AACR26, the third Plenary Session explores how artificial intelligence is being used to tackle complex cancer research. Learn more in AACR Annual Meeting News: buff.ly/5R61T47
#ICYMI Congratulations to the @uhn.ca researchers who secured over $8.6M through @innovation.ca's Innovation Fund to strengthen research infrastructure supporting preclinical modelling, AI, biomarker discovery & real-time health data. 🎉 🔗 Read more: www.uhnresearch.ca/news/4-07-20...
AIRCHECK is an open platform that turns DEL and E-ASMS screening data into AI-ready datasets, reproducible ML workflows, and benchmarks for hit discovery at scale @uhn.ca @thesgc.bsky.social. Already spanning 114 protein targets! AIRCHECK platform: aircheck.ai Paper: doi.org/10.26434/che...